For the FY of 2020 the revenues from sales of production decrease by 11% YoY.

Sopharma announced that for December 2020 the Company recorded an increase in sales of 27% compared to the same month of 2019, including 1% increase of domestic sales and 63% increase of export sales.

For the FY of 2020 the revenues from sales of production decrease by 11% compared to the same period of 2019, including 24% decrease of sales on the domestic market and 2% decrease of export sales.